ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply
Lancet
.
2021 Jun 12;397(10291):2248.
doi: 10.1016/S0140-6736(21)00976-4.
Authors
Merryn Voysey
1
,
Andrew J Pollard
2
Affiliations
1
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LE, UK.
2
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LE, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.
PMID:
34119059
DOI:
10.1016/S0140-6736(21)00976-4
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
Vaccines*
Substances
COVID-19 Vaccines
Vaccines
ChAdOx1 nCoV-19